Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum

In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the methylerythritol phosphate (MEP) pathway. Fosmidomycin is a specific inhibitor of the second enzyme of the MEP pathway, 1-deoxy-D...

Full description

Bibliographic Details
Main Authors: María B Cassera, Emilio F Merino, Valnice J Peres, Emilia A Kimura, Gerhard Wunderlich, Alejandro M Katzin
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2007-06-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000300019
_version_ 1797757062782910464
author María B Cassera
Emilio F Merino
Valnice J Peres
Emilia A Kimura
Gerhard Wunderlich
Alejandro M Katzin
author_facet María B Cassera
Emilio F Merino
Valnice J Peres
Emilia A Kimura
Gerhard Wunderlich
Alejandro M Katzin
author_sort María B Cassera
collection DOAJ
description In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the methylerythritol phosphate (MEP) pathway. Fosmidomycin is a specific inhibitor of the second enzyme of the MEP pathway, 1-deoxy-D-xylulose-5-phosphate reductoisomerase. We analyzed the effect of fosmidomycin on the levels of each intermediate and its metabolic requirement for the isoprenoid biosynthesis, such as dolichols and ubiquinones, throughout the intraerythrocytic cycle of P. falciparum. The steady-state RNA levels of the MEP pathway-associated genes were quantified by real-time polymerase chain reaction and correlated with the related metabolite levels. Our results indicate that MEP pathway metabolite peak precede maximum transcript abundance during the intraerythrocytic cycle. Fosmidomycin-treatment resulted in a decrease of the intermediate levels in the MEP pathway as well as in ubiquinone and dolichol biosynthesis. The MEP pathway associated transcripts were modestly altered by the drug, indicating that the parasite is not strongly responsive at the transcriptional level. This is the first study that compares the effect of fosmidomycin on the metabolic and transcript profiles in P. falciparum, which has only the MEP pathway for isoprenoid biosynthesis.
first_indexed 2024-03-12T18:10:37Z
format Article
id doaj.art-b7f069bcfde046a0946a99f0f209621b
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:10:37Z
publishDate 2007-06-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-b7f069bcfde046a0946a99f0f209621b2023-08-02T09:16:22ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602007-06-011023377384Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparumMaría B CasseraEmilio F MerinoValnice J PeresEmilia A KimuraGerhard WunderlichAlejandro M KatzinIn Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the methylerythritol phosphate (MEP) pathway. Fosmidomycin is a specific inhibitor of the second enzyme of the MEP pathway, 1-deoxy-D-xylulose-5-phosphate reductoisomerase. We analyzed the effect of fosmidomycin on the levels of each intermediate and its metabolic requirement for the isoprenoid biosynthesis, such as dolichols and ubiquinones, throughout the intraerythrocytic cycle of P. falciparum. The steady-state RNA levels of the MEP pathway-associated genes were quantified by real-time polymerase chain reaction and correlated with the related metabolite levels. Our results indicate that MEP pathway metabolite peak precede maximum transcript abundance during the intraerythrocytic cycle. Fosmidomycin-treatment resulted in a decrease of the intermediate levels in the MEP pathway as well as in ubiquinone and dolichol biosynthesis. The MEP pathway associated transcripts were modestly altered by the drug, indicating that the parasite is not strongly responsive at the transcriptional level. This is the first study that compares the effect of fosmidomycin on the metabolic and transcript profiles in P. falciparum, which has only the MEP pathway for isoprenoid biosynthesis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000300019Plasmodium falciparummalariafosmidomycinisoprenoid biosynthesisreal time polymerase chain reaction
spellingShingle María B Cassera
Emilio F Merino
Valnice J Peres
Emilia A Kimura
Gerhard Wunderlich
Alejandro M Katzin
Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
Memorias do Instituto Oswaldo Cruz
Plasmodium falciparum
malaria
fosmidomycin
isoprenoid biosynthesis
real time polymerase chain reaction
title Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
title_full Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
title_fullStr Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
title_full_unstemmed Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
title_short Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
title_sort effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in plasmodium falciparum
topic Plasmodium falciparum
malaria
fosmidomycin
isoprenoid biosynthesis
real time polymerase chain reaction
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000300019
work_keys_str_mv AT mariabcassera effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum
AT emiliofmerino effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum
AT valnicejperes effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum
AT emiliaakimura effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum
AT gerhardwunderlich effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum
AT alejandromkatzin effectoffosmidomycinonmetabolicandtranscriptprofilesofthemethylerythritolphosphatepathwayinplasmodiumfalciparum